BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2007
View Archived Issues
Phase I/II study of Oncohist in leukemia progresses
Read More
Activity seen with SNS-595 in acute leukemia patients
Read More
Preliminary phase I results with AT-9283 in hematological malignancies encouraging
Read More
Bupropion ameliorates methamphetamine dependence in some patients
Read More
New agents for musculoskeletal and connective tissue disorders claimed in recent patents
Read More
Novel therapeutic agents for Alzheimer's disease disclosed in recent patent literature
Read More
Update on Intra-Cellular Therapies' ITI-007/ITI-722 for schizophrenia and SMI
Read More
New agents for treating hematologic disorders reported in recent patents
Read More
Tissue-specific FAK gene deletion blocks mammary tumor progression
Read More
Ono enters license agreement with Nissan Chemical for new drug for thrombocytopenia
Read More
Novavax reports positive interim results from phase I/IIa trial of H5N1 vaccine
Read More
Nektar and Baxter expand agreement to develop PEGylated therapeutics for hemophilia
Read More
CFFT selects Triolex as drug candidate for lung inflammation linked with cystic fibrosis
Read More
Intercell submits BLA with FDA for Japanese encephalitis virus vaccine
Read More
Phase III clinical trial of Genitope's MyVax fails to meet primary endpoint
Read More
Peregrine gives update on its three lead clinical programs for bavituximab and Cotara
Read More
Actelion initiates RESTORA 1 phase III study of almorexant for primary insomnia
Read More
Corcept commences phase III Corlux trial for endogenous Cushing's syndrome
Read More
Pfizer receives FDA approvable letter for dalbavancin
Read More
GlaxoSmithKline and Santaris enter RNA antagonist alliance
Read More
Taxus Liberte drug-eluting stent receives CE mark for use in patients with diabetes
Read More
GlobeImmune initiates phase II GI-5005 trial in patients with chronic hepatitis C
Read More
ExonHit obtains approval to start phase II EHT-0202 trial in Alzheimer's disease
Read More
Galapagos enters strategic alliances with GlaxoSmithKline and Lilly
Read More
R-1507 antibody enters phase II sarcoma study
Read More
Phase II IPI-504 trial initiated in patients with non-small cell lung cancer
Read More
Conatus initiates phase II clinical trial for the treatment of hepatitis
Read More
VGX files IND for VGX-1027, a small molecule with antiinflammatory activity
Read More
Bazedoxifene receives second FDA approvable letter for prevention of osteoporosis
Read More
Noven reports FDA tentative approval of Stavzor valproic acid delayed release capsules
Read More